DIRC2 Blocking Peptide (Center)
€363.00
In stock
SKU
AC-BP20100c
Background:
This gene encodes a membrane-bound protein from the majorfacilitator superfamily of transporters. Disruption of this gene bytranslocation has been associated with haplo-insufficiency andrenal cell carcinomas. Alternatively spliced transcript variantshave been described, but their biological validity has not yet beendetermined.
Other Names:
Disrupted in renal carcinoma protein 2, Disrupted in renal cancer protein 2, DIRC2
Target/Specificity:
The synthetic peptide sequence is selected from aa 217-229 of HUMAN DIRC2
Gene Name: SLC49A4 (HGNC:16628)
Gene ID: 84925
Primary Accession: Q96SL1
Other Accession: Q8BFQ6; NP_116228.1
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
This gene encodes a membrane-bound protein from the majorfacilitator superfamily of transporters. Disruption of this gene bytranslocation has been associated with haplo-insufficiency andrenal cell carcinomas. Alternatively spliced transcript variantshave been described, but their biological validity has not yet beendetermined.
Other Names:
Disrupted in renal carcinoma protein 2, Disrupted in renal cancer protein 2, DIRC2
Target/Specificity:
The synthetic peptide sequence is selected from aa 217-229 of HUMAN DIRC2
Gene Name: SLC49A4 (HGNC:16628)
Gene ID: 84925
Primary Accession: Q96SL1
Other Accession: Q8BFQ6; NP_116228.1
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review